Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Idoia Bolinaga Ayala

Idoia Bolinaga Ayala

Institutions of which they are part

Predoctoral researcher
Protein kinases in cancer research
Vall Hebron Institut de Recerca
Idoia Bolinaga Ayala

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán , Nora Diéguez Martínez, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, María de los Ángeles Rodríguez Sánchez, Maria Luz Uria Oficialdegui , Maria Jose Pérez García, Miguel Segura Ginard, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, M Mar Mañu Pereira, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Lorena Valero Arrese, Raquel Anta Peña, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Elisabet Megías Roda, Raquel Hladun Alvaro, Ariadna Boloix Amenós, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia , Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Gabriel Osvaldo Gallo , Elena Andretta , Roberta Antonelli , Claire Diot , Amira Idrizovic
Funding agency: AGAUR
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 31/12/2024

Related news

Última taula rodona de la Jornada.

L’experiència del pacient i els últims avenços en recerca i innovació protagonitzen la Jornada del Dia Mundial contra el C

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

Dr. José Miguel Lizcano i Dra. Nora Diéguez

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

Inhibition of the ERK5 protein kinase reduces the proliferation and survival of endometrial cancer cells, and potentiates standard chemotherapy.

Microscopi

Improving the prevention, diagnosis and treatment of childhood and adult cancer, among the objectives of Vall d'Hebron research

On World Cancer Research Day, we highlight the impact of VHIR projects in the field of oncology.

See more

Related professionals

Laia Grau Romero

Laia Grau Romero

Research technician
Genetics Medicine
Read more
Rubén Escribá Piera

Rubén Escribá Piera

Postdoctoral researcher
Transfusional Medicine
Read more
Danielle Nicole Vandeperre Venegas

Danielle Nicole Vandeperre Venegas

Administrative
Promotion of Clinical Research
Clinical Research Development Area
Read more
Vanesa Paola Flores Escobar

Vanesa Paola Flores Escobar

Research technician
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.